Spravato represents a groundbreaking therapy for individuals suffering from treatment-resistant depression. When combined with traditional antidepressant medications, Spravato has the potential to alleviate the symptoms of major depressive disorder, even in cases where other treatment methods have proven ineffective.

Unlike conventional oral medications, Spravato is administered as a nasal spray. Loving Care Mental Health Service operates as a certified Spravato clinic, where trained practitioners provide the treatment safely. Patients are required to receive their medication at the clinic, where they will be monitored for a duration of two hours post-administration to ensure their safety and to observe for any possible adverse effects.

The active component of Spravato is esketamine, a newly patented variant of ketamine that has received approval from the FDA.

Ketamine is a medication predominantly utilized for sedation and alleviating pain. In recent years, its significance in the management of depression has been increasingly acknowledged, leading to its application as a targeted treatment for depression and various mood disorders.

Research indicates that as many as 75% of individuals undergoing ketamine therapy for treatment-resistant depression exhibit favorable responses to the intervention.

Loving Care Mental Health Service acknowledges the efficacy of ketamine in addressing depression, especially in cases that are resistant to conventional treatments. The facility provides Spravato, an intranasal esketamine spray, as part of its treatment offerings.

Spravato is an essential element of the ketamine-assisted psychotherapy program at Loving Care Mental Health Service.

Spravato is a good alternative, as it is a simple spray delivered into your nose that is covered by most insurances.

To ensure you receive the full benefits of your treatment, it is important to participate in a series of sessions. While the specific regimen may differ for each patient, a standard Spravato treatment plan typically includes two sessions per week for the first four weeks, followed by one session per week for the subsequent four weeks.

Your Spravato sessions will be conducted under supervision at Loving Care Mental Health Service. It is essential to arrange for someone to drive you home afterwards, as you may experience side effects such as drowsiness or reduced responsiveness.